Edesa Biotech
EDSA
12 hedge funds and large institutions have $910K invested in Edesa Biotech in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
9% more funds holding
Funds holding: 11 → 12 (+1)
0.07% more ownership
Funds ownership: 0.23% → 0.29% (+0.07%)
26% less capital invested
Capital invested by funds: $1.22M → $910K (-$314K)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$433K |
| 2 |
Two Sigma Investments
New York
|
+$131K |
| 3 |
Stifel Financial
St. Louis,
Missouri
|
+$45.6K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$45.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIA
FNY Investment Advisers
New York
|
-$265K |
| 2 |
BBA
Braun-Bostich & Associates
Canonsburg,
Pennsylvania
|
-$25K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$7.44K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$163 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FIA
1
FNY Investment Advisers
New York
| $318K | -$265K | -6,487 | -38% |
|
|
2
Renaissance Technologies
New York
| $315K | +$433K | +10,586 | New |
|
|
3
Stifel Financial
St. Louis,
Missouri
| $100K | +$45.6K | +1,116 | +50% |
|
|
4
Two Sigma Investments
New York
| $96K | +$131K | +3,213 | New |
|
|
5
Vanguard Group
Malvern,
Pennsylvania
| $81K | +$45.5K | +1,114 | +70% |
|
|
BBA
6
Braun-Bostich & Associates
Canonsburg,
Pennsylvania
| – | -$25K | -446 | Closed |
|
|
7
UBS Group
Zurich,
Switzerland
| – | -$7.44K | -182 | -97% |
|
|
8
Osaic Holdings
Scottsdale,
Arizona
| – | -$163 | -4 | -21% |
|
EDSA Hedge Fund Activity: Q4 2020 in Review
12 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q4 2020, worth a combined $910K — down 26% from $1.22M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new EDSA positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 3 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $433K. The largest seller was FNY Investment Advisers, cutting an estimated $265K.
- 12 institutional investors held Edesa Biotech (EDSA) as of Q4 2020, up from 11 in Q3 2020.
- Funds reported $910K of Edesa Biotech stock for Q4 2020, down 26% quarter-over-quarter.
- 2 funds opened new Edesa Biotech positions in Q4 2020 and 1 closed out, a net change of +1 holder.
- The largest Edesa Biotech buyer in Q4 2020 was Renaissance Technologies, an estimated $433K added.
- The largest Edesa Biotech seller in Q4 2020 was FNY Investment Advisers, an estimated $265K sold.
Based on aggregated 13F filings for Q4 2020.